RCC, RENAL CELL CANCER
Clinical trials for RCC, RENAL CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new RCC, RENAL CELL CANCER trials appear
Sign up with your email to follow new studies for RCC, RENAL CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough kidney cancers: testing a powerful drug combo
Disease control Not yet recruitingThis study is testing a new combination of drugs for people with advanced kidney cancer that has worsened after their first treatment. It combines an immunotherapy (iparomlimab and tuvonralimab) with one of two targeted drugs (lenvatinib or axitinib). The main goal is to see if t…
Matched conditions: RCC, RENAL CELL CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
Simple blood test could tell doctors which cancer drugs will work
Diagnosis Not yet recruitingThis study aims to develop a blood test that predicts whether cancer patients will benefit from immunotherapy drugs. Researchers will analyze blood samples from 600 patients with various cancers before they start treatment. The goal is to create a tool that helps doctors choose t…
Matched conditions: RCC, RENAL CELL CANCER
Sponsor: OncoHost Ltd. • Aim: Diagnosis
Last updated Apr 04, 2026 03:51 UTC